Target intelligence / Profile preview

T cell receptor alpha joining 7 (TRAJ7)

Target
TRAJ7
Molecular classification
Other
01

Overview

TRAJ7 (T cell receptor alpha joining 7) is a gene segment within the T cell receptor alpha locus, encoding one of many possible joining regions recombined during T cell development. VJ recombination in the alpha locus uses TRAJ segments like TRAJ7 to generate the antigen-binding diversity found in T cell receptors. TRAJ7 does not encode a protein by itself; instead, it contributes as a module to the assembled variable region of the receptor as part of somatic DNA rearrangement[1][3][4]. TRAJ7 is not a pharmacological target, but it is essential for immune diversity and function as part of the broader TCR complex[2][5]. If you require information on the complete *T cell receptor alpha chain* or the *T cell receptor complex*—which are canonical therapeutic targets—please clarify, as TRAJ7 alone is a joining segment and not a conventional drug target[1][2].

Other names
TRAJ7Gm16919NCBI Gene: 28748Ensembl: ENSG00000211882
02

Biological functions

Genetic recombination in T cell developmentContributing to antigen specificity and diversity of T cell receptor

Beyond the preview

Go deeper on T cell receptor alpha joining 7 (TRAJ7).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on T cell receptor alpha joining 7 (TRAJ7).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call